Citadel Advisors’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $204K | Buy |
+3,407
| New | +$204K | ﹤0.01% | 4987 |
|
|
2025
Q1 | – | Sell |
-5,304
| Closed | -$292K | – | 6430 |
|
|
2024
Q4 | $292K | Buy |
+5,304
| New | +$292K | ﹤0.01% | 4542 |
|
|
2024
Q3 | – | Sell |
-17,750
| Closed | -$780K | – | 6230 |
|
|
2024
Q2 | $780K | Sell |
17,750
-14,003
| -44% | -$615K | ﹤0.01% | 3305 |
|
|
2024
Q1 | $1.4M | Buy |
31,753
+11,527
| +57% | +$507K | ﹤0.01% | 2826 |
|
|
2023
Q4 | $960K | Buy |
20,226
+2,695
| +15% | +$128K | ﹤0.01% | 3078 |
|
|
2023
Q3 | $778K | Sell |
17,531
-16,346
| -48% | -$725K | ﹤0.01% | 3302 |
|
|
2023
Q2 | $1.62M | Sell |
33,877
-18,383
| -35% | -$878K | ﹤0.01% | 2594 |
|
|
2023
Q1 | $2.06M | Buy |
52,260
+37,115
| +245% | +$1.46M | ﹤0.01% | 2523 |
|
|
2022
Q4 | $428K | Buy |
+15,145
| New | +$428K | ﹤0.01% | 4000 |
|
|
2022
Q2 | – | Sell |
-5,617
| Closed | -$252K | – | 6464 |
|
|
2022
Q1 | $252K | Buy |
+5,617
| New | +$252K | ﹤0.01% | 5097 |
|
|
2021
Q4 | – | Sell |
-7,086
| Closed | -$238K | – | 6806 |
|
|
2021
Q3 | $238K | Buy |
+7,086
| New | +$238K | ﹤0.01% | 5238 |
|
|
2020
Q4 | – | Sell |
-12,610
| Closed | -$270K | – | 5320 |
|
|
2020
Q3 | $270K | Sell |
12,610
-11,118
| -47% | -$238K | ﹤0.01% | 3909 |
|
|
2020
Q2 | $550K | Buy |
23,728
+3,682
| +18% | +$85.3K | ﹤0.01% | 3382 |
|
|
2020
Q1 | $428K | Buy |
+20,046
| New | +$428K | ﹤0.01% | 3516 |
|